| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.086 | 0.8 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | LFM-A13 | GDSC1000 | pan-cancer | AAC | 0.0094 | 0.8 |
| mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | 0.0093 | 0.8 |
| mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | 0.0096 | 0.8 |
| mRNA | GW843682X | GDSC1000 | pan-cancer | AAC | 0.014 | 0.8 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | 0.009 | 0.8 |
| mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | 0.0098 | 0.8 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |